Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis-Reference-Cited by-同舟云学术

Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis

Published:2020-02-27 Issue:4 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Kashyap Sonu,Hein Kyaw Zaw,Chini Claudia C.S.,Lika Jorgo^ORCID,Warner Gina M.,Bale Laurie K.,Torres Vicente E.,Harris Peter C.,Oxvig Claus,Conover Cheryl A.,Chini Eduardo N.

Funder

NIDDK

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/135700/files/pdf

Reference96 articles.

1. Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs;Tan;Biochim Biophys Acta,2011

2. Autosomal dominant polycystic kidney disease

3. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016

4. Interventions for preventing the progression of autosomal dominant polycystic kidney disease;Bolignano;Cochrane Database Syst Rev,2015

5. Cyst formation and growth in autosomal dominant polycystic kidney disease

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease;iScience;2024-09

2. Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy;International Journal of Molecular Sciences;2024-02-08

3. Transcriptomic profiling of Polycystic Kidney Disease identifies paracrine factors in the early cyst microenvironment;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

4. Identification and Properties of TRPV4 Mutant Channels Present in Polycystic Kidney Disease Patients;Function;2024

5. Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature;Nutrients;2023-06-03